Immunovia to Significantly Restructure to Focus Resources on its Next-Generation Blood Test for Pancreatic Cancer Detection

Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company focused on early detection of pancreatic cancer, today announced…

Skanska builds hospital in Lakeland, Florida, USA, for USD 109M, about SEK 1.1 billion

Skanska has signed a contract with an existing client to build a hospital in Lakeland, Florida, USA.…

Global CAR-T Cell Therapy Market Report 2023: Rise in Awareness Regarding CAR T-Cell Therapy Drives Growth

The “CAR-T Cell Therapy Market Share, Size, Trends, Industry Analysis Report, By Target Antigen, By Indication, By…

Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and…

Blister Packaging Market to be Worth $46.72 Billion by 2030: Grand View Research, Inc.

The global blister packaging market size is expected to reach USD 46.72 billion by 2030, expanding at 7.2% CAGR from…

Lo.Li. Pharma International and its International Partners Achieve a New World Record to Raise Awareness About Innovative Options for Managing PCOS and Infertility

The Society of Human Reproduction and Embryology (ESHRE) annual meeting witnessed a historic event as people…

Spectrometry Industry Unlocks Growth Potentials in NMR Spectroscopy – Grand View Research, Inc

The global spectrometry industry size will witness robust growth on the back of growing applications across…

UNION therapeutics announces positive topline results from the OSIRIS investigator-initiated proof-of-concept study of oral orismilast in patients with hidradenitis suppurativa

UNION therapeutics A/S (UNION), a privately-held, clinical stage, pharmaceutical development company focused on immunology and infectious…

Interius BioTherapeutics Highlights Strong Preclinical Data Supporting In Vivo Chimeric Antigen Receptor (CAR) Vector Evaluation in Clinic

 Interius BioTherapeutics, a leading developer of in vivo cell-specific genetic medicine therapeutics, today announced the presentation of compelling…

HSS Announces Dr. Bryan Kelly to Succeed CEO Louis Shapiro on September 5

Hospital for Special Surgery (HSS) today announced its phased leadership transition will be completed on September 5,…